Structures by: Arshad M. N.
Total: 170
(2<i>R</i>)-2-Benzenesulfonamido-2-phenylethanoic acid
C14H13NO4S
Acta Crystallographica Section E (2009) 65, 10 o2436
a=8.2464(8)Å b=5.3251(4)Å c=15.3642(15)Å
α=90.00° β=100.384(3)° γ=90.00°
1-Ammonionaphthalene-2-sulfonate
C10H9NO3S
Acta Crystallographica Section E (2009) 65, 10 o2505
a=9.4337(3)Å b=10.6359(4)Å c=18.6775(6)Å
α=90.00° β=90.00° γ=90.00°
Methyl 2-[methyl(methylsulfonyl)amino]benzoate
C10H13NO4S
Acta Crystallographica Section E (2009) 65, 10 o2588
a=8.7476(4)Å b=10.2081(4)Å c=13.8377(7)Å
α=90.00° β=108.347(3)° γ=90.00°
<i>N</i>-Cyclohexyl-<i>N</i>-methylbenzenesulfonamide
C13H19NO2S
Acta Crystallographica Section E (2009) 65, 11 o2892
a=9.2729(5)Å b=12.1182(7)Å c=12.5801(7)Å
α=90.00° β=109.103(2)° γ=90.00°
<i>N</i>-Cyclohexyl-<i>N</i>-ethylbenzenesulfonamide
C14H21NO2S
Acta Crystallographica Section E (2009) 65, 11 o2867
a=18.1950(10)Å b=12.9799(7)Å c=12.7327(6)Å
α=90.00° β=108.587(3)° γ=90.00°
2-(Phenylsulfanyl)pyridine-3-carboxylic acid
C12H9NO2S
Acta Crystallographica Section E (2009) 65, 11 o2662
a=7.2201(4)Å b=7.6653(4)Å c=19.9537(11)Å
α=97.895(3)° β=98.520(3)° γ=91.661(3)°
4-Hydroxy-<i>N</i>-(2,4,6-tribromophenyl)-2<i>H</i>-1,2-benzothiazine-3-carboxamide 1,1-dioxide
C15H9Br3N2O4S
Acta Crystallographica Section E (2009) 65, 12 o2998
a=7.5082(4)Å b=8.7486(6)Å c=13.0669(9)Å
α=83.618(2)° β=86.280(2)° γ=87.684(2)°
Methyl 4-hydroxy-2-propyl-2<i>H</i>-1,2-benzothiazine-3-carboxylate 1,1-dioxide
C13H15NO5S
Acta Crystallographica Section E (2009) 65, 12 o3025
a=12.4398(6)Å b=8.7538(5)Å c=12.7288(7)Å
α=90.00° β=90.00° γ=90.00°
Methyl 4-hydroxy-2-(prop-2-en-1-yl)-2<i>H</i>-1,2-benzothiazine-3-carboxylate 1,1-dioxide
C13H13NO5S
Acta Crystallographica Section E (2009) 65, 12 o3077
a=12.4289(10)Å b=8.3706(8)Å c=13.0132(11)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-Benzyl-<i>N</i>-cyclohexylbenzenesulfonamide
C19H23NO2S
Acta Crystallographica Section E (2009) 65, 12 o3053
a=9.1996(5)Å b=11.0406(5)Å c=17.1897(9)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-Cyclohexyl-<i>N</i>-(prop-2-en-1-yl)benzenesulfonamide
C15H21NO2S
Acta Crystallographica Section E (2009) 65, 12 o3102
a=8.4911(5)Å b=11.4176(6)Å c=15.6274(10)Å
α=90.00° β=94.188(3)° γ=90.00°
<i>N</i>-Benzyl-<i>N</i>-cyclohexyl-4-methylbenzenesulfonamide
C20H25NO2S
Acta Crystallographica Section E (2009) 65, 12 o3109
a=9.0702(4)Å b=11.1054(5)Å c=18.1971(8)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-cyclohexyl-<i>N</i>-ethylbenzenesulfonamide
C14H21NO2S
Acta Crystallographica Section E (2009) 65, 12 o3107
a=8.3837(4)Å b=11.4467(5)Å c=15.1488(7)Å
α=90.00° β=92.541(2)° γ=90.00°
<i>N</i>-(Phenylsulfonyl)-L-asparagine
C10H12N2O5S
Acta Crystallographica Section E (2009) 65, 12 o3229
a=10.5479(6)Å b=5.1587(3)Å c=11.0157(7)Å
α=90.00° β=92.011(3)° γ=90.00°
<i>N</i>-Cyclohexyl-<i>N</i>-ethyl-4-methylbenzenesulfonamide
C15H23NO2S
Acta Crystallographica Section E (2010) 66, 1 o102
a=12.2269(5)Å b=7.5818(3)Å c=16.3045(6)Å
α=90.00° β=92.495(2)° γ=90.00°
<i>N</i>-[4-(<i>p</i>-Toluenesulfonamido)phenylsulfonyl]acetamide
C15H16N2O5S2
Acta Crystallographica Section E (2010) 66, 2 o299
a=9.8077(4)Å b=10.0782(4)Å c=17.3081(7)Å
α=90.00° β=100.290(2)° γ=90.00°
<i>N</i>-(<i>p</i>-Tolylsulfonyl)-L-asparagine
C11H14N2O5S
Acta Crystallographica Section E (2010) 66, 3 o541
a=8.7566(6)Å b=22.900(2)Å c=6.9692(7)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-Ethyl-4-methyl-<i>N</i>-phenylbenzenesulfonamide
C15H17NO2S
Acta Crystallographica Section E (2010) 66, 4 o979
a=14.1248(6)Å b=10.4126(5)Å c=19.7639(10)Å
α=90.00° β=90.00° γ=90.00°
1,3-Bis(bromomethyl)-2-nitrobenzene
C8H7Br2NO2
Acta Crystallographica Section E (2010) 66, 4 o834
a=7.7837(13)Å b=7.7573(13)Å c=15.938(3)Å
α=90.00° β=90.933(3)° γ=90.00°
<i>N</i>-Cyclohexyl-<i>N</i>-propyl-4-methylbenzenesulfonamide
C16H25NO2S
Acta Crystallographica Section E (2010) 66, 4 o741
a=7.8207(5)Å b=25.2915(16)Å c=8.3135(6)Å
α=90.00° β=102.411(3)° γ=90.00°
Methyl 2-(1,1,3-trioxo-2,3-dihydro-1,2-benzothiazol-2-yl)acetate
C10H9NO5S
Acta Crystallographica Section E (2010) 66, 5 o1028
a=8.9418(4)Å b=12.7595(6)Å c=10.3145(5)Å
α=90.00° β=107.3000(10)° γ=90.00°
3-Chlorobenzohydrazide
C7H7ClN2O
Acta Crystallographica Section E (2010) 66, 8 o2169
a=16.2005(15)Å b=3.8165(4)Å c=12.7646(13)Å
α=90.00° β=108.030(5)° γ=90.00°
(2<i>S</i>)-3-Carbamoyl-2-(4-methoxybenzenesulfonamido)propanoic acid
C11H14N2O6S
Acta Crystallographica Section E (2010) 66, 10 o2596
a=7.14620(10)Å b=8.9874(2)Å c=11.1418(2)Å
α=90.00° β=108.0900(10)° γ=90.00°
<i>N</i>-(2-Methoxyphenyl)-4-methylbenzenesulfonamide
C14H15NO3S
Acta Crystallographica Section E (2010) 66, 11 o2976
a=12.7395(9)Å b=11.4906(6)Å c=18.6968(10)Å
α=90.00° β=90.00° γ=90.00°
3,3,6-Tribromo-1-methyl-1<i>H</i>-2,1-benzothiazin-4(3<i>H</i>)-one 2,2-dioxide
C9H6Br3NO3S
Acta Crystallographica Section E (2010) 66, 12 o3109
a=14.9220(10)Å b=12.1310(8)Å c=7.0811(4)Å
α=90.00° β=90.00° γ=90.00°
2-Ethyl-2,3-dihydro-1,2-benzothiazole-1,1,3-trione
C9H9NO3S
Acta Crystallographica Section E (2011) 67, 4 o887
a=10.4559(5)Å b=7.5484(5)Å c=12.9408(7)Å
α=90° β=105.863(2)° γ=90°
2-(4-Chlorobenzamido)acetic acid
C9H8ClNO3
Acta Crystallographica Section E (2011) 67, 4 o916
a=10.5035(2)Å b=13.2105(4)Å c=7.1226(2)Å
α=90° β=102.2030(10)° γ=90°
<i>N</i>-Cyclohexyl-4-methoxybenzenesulfonamide
C13H19NO3S
Acta Crystallographica Section E (2011) 67, 4 o885-o886
a=17.2644(12)Å b=20.4707(16)Å c=7.9139(5)Å
α=90° β=90° γ=90°
6-Bromo-4-hydrazinylidene-1-methyl-3<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C9H10BrN3O2S
Acta Crystallographica Section E (2011) 67, 8 o2078
a=10.1483(5)Å b=9.6375(4)Å c=11.2118(5)Å
α=90.00° β=92.278(2)° γ=90.00°
Dicarbonyldichlorido(<i>N</i>,<i>N</i>,<i>N</i>',<i>N</i>'-tetramethylethylenediamine)ruthenium(II)
C8H16Cl2N2O2Ru1
Acta Crystallographica Section E (2011) 67, 7 m925
a=7.463(6)Å b=14.579(6)Å c=12.718(12)Å
α=90.00° β=106.37(8)° γ=90.00°
Methyl 2-benzyl-4-hydroxy-1,1-dioxo-1,2,3,4-tetrahydro-1λ^6^,2-benzothiazine-3-carboxylate
C17H15NO5S
Acta Crystallographica Section E (2011) 67, 7 o1588-o1589
a=9.4920(15)Å b=10.9607(17)Å c=15.050(2)Å
α=90.00° β=99.758(2)° γ=90.00°
4-Hydrazinylidene-1-methyl-3<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C9H11N3O2S
Acta Crystallographica Section E (2011) 67, 8 o2038
a=6.6643(2)Å b=9.6834(3)Å c=15.5890(5)Å
α=90.00° β=97.6990(10)° γ=90.00°
Methyl 1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate monohydrate
C13H14N2O3,H2O
Acta Crystallographica Section E (2012) 68, 3 o630-o631
a=4.69890(10)Å b=23.7246(7)Å c=11.3635(3)Å
α=90.00° β=91.6460(10)° γ=90.00°
Methyl 2-(but-3-enyl)-4-hydroxy-1,1-dioxo-2<i>H</i>-1λ^6^,2-benzothiazine-3-carboxylate
C14H15NO5S
Acta Crystallographica Section E (2012) 68, 6 o1926
a=25.265(8)Å b=8.929(3)Å c=12.584(4)Å
α=90.00° β=90.00° γ=90.00°
2,5-Dichloro-<i>N</i>-(3-methylphenyl)benzenesulfonamide
C13H11Cl2NO2S
Acta Crystallographica Section E (2012) 68, 8 o2476
a=9.0361(10)Å b=11.6937(11)Å c=13.6904(15)Å
α=90.00° β=100.588(3)° γ=90.00°
1-(Benzotriazol-1-yl)-2-bromoethanone
C8H6BrN3O
Acta Crystallographica Section E (2012) 68, 11 o3179
a=12.4815(4)Å b=4.72070(10)Å c=15.4780(5)Å
α=90.00° β=103.468(3)° γ=90.00°
Methyl 4-hydroxy-2-methoxycarbonylmethyl-1,1-dioxo-1,2-dihydro-1λ^6^,2-benzothiazine-3-carboxylate
C13H13NO7S
Acta Crystallographica Section E (2011) 67, 9 o2527
a=8.9128(14)Å b=12.414(2)Å c=13.443(2)Å
α=79.784(2)° β=72.981(3)° γ=88.503(3)°
Benzyl 2-{4-[2-(4-chlorobenzoylamino)ethyl]phenoxy}-2-methylpropionate
C26H26ClNO4
Acta Crystallographica Section E (2011) 67, 10 o2803
a=5.54800(10)Å b=11.0716(3)Å c=18.9641(5)Å
α=82.2470(10)° β=86.9150(10)° γ=85.6740(10)°
<i>N</i>'-(phenylsulfonyl)carbamimidic azide
C7H7N5O2S
Acta Crystallographica Section E (2011) 67, 10 o2703
a=7.0399(2)Å b=7.1714(2)Å c=10.3670(3)Å
α=90.2670(10)° β=98.9970(10)° γ=110.3580(10)°
6-Bromo-4-(2-cyclohexylidenehydrazin-1-ylidene)-1-methyl-2,2-dioxo-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine
C15H18BrN3O2S
Acta Crystallographica Section E (2012) 68, 7 o2088-o2089
a=9.9357(2)Å b=11.2614(3)Å c=15.8263(3)Å
α=110.6250(10)° β=91.525(3)° γ=102.879(4)°
Ethyl (<i>Z</i>)-2-chloro-2-[2-(4-methoxyphenyl)hydrazin-1-ylidene]acetate
C11H13ClN2O3
Acta Crystallographica Section E (2012) 68, 12 o3274
a=4.7480(2)Å b=9.9256(4)Å c=13.3084(4)Å
α=90.00° β=91.468(3)° γ=90.00°
1-[(1<i>Z</i>)-1-Ferrocenylethylidene]thiocarbonohydrazide
C13H16FeN4S
Acta Crystallographica Section E (2012) 68, 12 m1439
a=6.4560(2)Å b=13.0664(3)Å c=15.8559(4)Å
α=90.00° β=91.028(2)° γ=90.00°
2-{(<i>E</i>)-[(2<i>Z</i>)-(3-Chloro-1-methyl-2,2-dioxo-3,4-dihydro- 1<i>H</i>-2,1-benzothiazin-4-ylidene)hydrazinylidene]methyl}phenol
C16H14ClN3O3S
Acta Crystallographica Section E (2012) 68, 2 o307
a=7.0973(5)Å b=12.0957(7)Å c=18.7396(13)Å
α=90.00° β=96.058(4)° γ=90.00°
1,3-Diethyl-2-sulfanylidene-5-(2,4,5-trimethoxybenzylidene)-1,3-diazinane-4,6-dione
C18H22N2O5S
Acta Crystallographica Section E (2013) 69, 1 o49
a=7.97110(10)Å b=17.4106(3)Å c=13.5265(2)Å
α=90.00° β=99.237(2)° γ=90.00°
2-Chloro-4-(2-iodobenzenesulfonamido)benzoic acid
C13H9ClINO4S
Acta Crystallographica Section E (2011) 67, 6 o1327
a=14.1522(8)Å b=7.3203(4)Å c=14.7193(8)Å
α=90.00° β=104.892(2)° γ=90.00°
Methyl 4-hydroxy-2-isopropyl-1,1-dioxo-2<i>H</i>-1,2-benzothiazine-3-carboxylate
C13H15NO5S
Acta Crystallographica Section E (2011) 67, 7 o1823-o1824
a=11.3896(6)Å b=9.8421(5)Å c=12.7680(7)Å
α=90.00° β=105.7820(10)° γ=90.00°
6-Bromo-1-methyl-4-[2-(4-methylbenzylidene)hydrazinylidene]-3<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C17H16BrN3O2S
Acta Crystallographica Section E (2011) 67, 8 o2092
a=9.1077(6)Å b=6.8328(4)Å c=14.1765(9)Å
α=90.00° β=96.807(3)° γ=90.00°
<i>N</i>-[Amino(azido)methylidene]-4-methylbenzenesulfonamide
C8H9N5O2S
Acta Crystallographica Section E (2011) 67, 8 o2140
a=6.8986(2)Å b=7.2146(2)Å c=11.3771(3)Å
α=92.2440(10)° β=93.6150(10)° γ=110.5050(10)°
<i>N</i>-(2-Bromophenyl)-4-methyl-<i>N</i>-(4-methylphenylsulfonyl)benzenesulfonamide
C20H18BrNO4S2
Acta Crystallographica Section E (2011) 67, 9 o2356
a=10.5819(15)Å b=13.1465(19)Å c=14.235(2)Å
α=90.00° β=95.478(2)° γ=90.00°
(2<i>S</i>)-3-(1<i>H</i>-Indol-3-yl)-2-(4-methylbenzenesulfonamido)propionic acid monohydrate
C18H18N2O4S,H2O
Acta Crystallographica Section E (2011) 67, 9 o2325
a=8.4531(10)Å b=5.2521(5)Å c=20.867(2)Å
α=90.00° β=98.056(4)° γ=90.00°
<i>N</i>'-[(<i>E</i>)-1-(4-Bromophenyl)ethylidene]-4-hydroxy-2-methyl-1,1-dioxo-2<i>H</i>-1,2-benzothiazine-3-carbohydrazide
C18H16BrN3O4S
Acta Crystallographica Section E (2011) 67, 10 o2613
a=14.692(2)Å b=16.562(2)Å c=7.5254(10)Å
α=90.00° β=104.8200(10)° γ=90.00°
2-Imino-3-(2-nitrophenyl)-1,3-thiazolidin-4-one
C9H7N3O3S
Acta Crystallographica Section E (2011) 67, 10 o2564
a=7.3036(5)Å b=16.4409(10)Å c=8.2455(5)Å
α=90.00° β=102.1321(9)° γ=90.00°
Methyl 4-hydroxy-1,1-dioxo-2-(2-phenylethyl)-2<i>H</i>-1λ^6^,2-benzothiazine-3-carboxylate
C18H17NO5S
Acta Crystallographica Section E (2011) 67, 12 o3445
a=9.018(2)Å b=19.026(4)Å c=10.193(2)Å
α=90.00° β=106.441(3)° γ=90.00°
<i>N</i>'-[(<i>Z</i>)-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)methylidene]-2-hydroxybenzohydrazide
C19H18N4O3
Acta Crystallographica Section E (2012) 68, 2 o352
a=25.2357(6)Å b=8.5624(2)Å c=16.0329(4)Å
α=90.00° β=104.0480(10)° γ=90.00°
[4,4'-(Ethane-1,2-diyldinitrilo)bis(pent-2-en-2-olato)]copper(II) 0.25-hydrate
C12H18CuN2O2,0.25(H2O)
Acta Crystallographica Section E (2012) 68, 5 m670
a=17.0029(7)Å b=8.0198(3)Å c=19.6532(7)Å
α=90.00° β=90.00° γ=90.00°
1-Ethyl-4-[1-(1-phenylethylidene)hydrazin-2-ylidene]-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C18H19N3O2S
Acta Crystallographica Section E (2012) 68, 6 o1927
a=9.7278(3)Å b=12.4327(3)Å c=14.2607(4)Å
α=90.00° β=100.7250(10)° γ=90.00°
Methyl 2-butyl-4-hydroxy-1,1-dioxo-2<i>H</i>-1,2-benzothiazine-3-carboxylate
C14H17NO5S
Acta Crystallographica Section E (2012) 68, 6 o1663
a=25.173(7)Å b=9.280(2)Å c=12.531(3)Å
α=90.00° β=91.741(3)° γ=90.00°
<i>N</i>-(2,3-Dihydro-1,4-benzodioxin-6-yl)-4-fluorobenzenesulfonamide
C14H12FNO4S
Acta Crystallographica Section E (2012) 68, 8 o2433
a=5.1542(5)Å b=22.237(3)Å c=12.0706(13)Å
α=90.00° β=94.422(3)° γ=90.00°
4-Methyl-2-(2-nitrobenzenesulfonamido)pentanoic acid
C12H16N2O6S
Acta Crystallographica Section E (2012) 68, 8 o2573
a=6.9593(5)Å b=10.7560(8)Å c=20.8431(14)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 2-benzenesulfonamido-4-methylpentanoate
C14H21NO4S
Acta Crystallographica Section E (2012) 68, 10 o2874
a=5.3084(3)Å b=9.5507(7)Å c=31.315(2)Å
α=90.00° β=90.00° γ=90.00°
2-Benzenesulfonamido-3-methylbutyric acid
C11H15NO4S
Acta Crystallographica Section E (2012) 68, 9 o2665
a=5.4954(3)Å b=15.5097(10)Å c=15.5106(9)Å
α=90.00° β=94.043(3)° γ=90.00°
1-(1<i>H</i>-1,2,3-Benzotriazol-1-yl)-2-(4-methoxyphenyl)ethanone
C15H13N3O2
Acta Crystallographica Section E (2012) 68, 11 o3221
a=5.42090(10)Å b=24.4894(5)Å c=10.0555(2)Å
α=90.00° β=98.552(2)° γ=90.00°
(<i>Z</i>)-Ethyl 2-chloro-2-[2-(4-methylphenyl)hydrazono]acetate
C11H13ClN2O2
Acta Crystallographica Section E (2012) 68, 12 o3420
a=4.61520(10)Å b=9.94440(10)Å c=26.3152(3)Å
α=90.00° β=90.6920(10)° γ=90.00°
<i>cis</i>-Dichloridobis(<i>N</i>,<i>N</i>,<i>N</i>',<i>N</i>'-tetramethylethane-1,2-diamine)platinum(II)
C6H16Cl2N2Pt
Acta Crystallographica Section E (2012) 68, 12 m1562
a=11.8893(2)Å b=6.02070(10)Å c=15.8036(3)Å
α=90.00° β=110.549(2)° γ=90.00°
2-(Naphthalene-2-sulfonamido)-3-phenylpropanoic acid
C19H17NO4S
Acta Crystallographica Section E (2013) 69, 2 o194
a=8.0694(2)Å b=15.2168(4)Å c=14.0996(3)Å
α=90.00° β=92.505(2)° γ=90.00°
2-[(2-Hydroxynaphthalen-1-yl)methylideneamino]-5,6,7,8-tetrahydro-4<i>H</i>-cyclohepta[<i>b</i>]thiophene-3-carbonitrile
C21H18N2OS
Acta Crystallographica Section E (2013) 69, 2 o193
a=13.5472(2)Å b=14.4747(4)Å c=35.7902(6)Å
α=90.00° β=90.00° γ=90.00°
5-Acetyl-3-(5-phenyl-1<i>H</i>-pyrazol-3-yl)-1,3,4-thiadiazol-2(3<i>H</i>)-one monohydrate
C13H10N4O2S,H2O1
Acta Crystallographica Section E (2013) 69, 5 o798
a=7.6084(2)Å b=25.5788(4)Å c=7.6524(2)Å
α=90.00° β=111.974(3)° γ=90.00°
2-Chloro-6-(2,3-dichlorobenzenesulfonamido)benzoic acid
C13H8Cl3NO4S
Acta Crystallographica Section E (2013) 69, 6 o832
a=9.0164(3)Å b=18.6017(5)Å c=9.8574(3)Å
α=90.00° β=111.653(3)° γ=90.00°
1-Benzoyl-3-(4-fluorophenyl)thiourea
C14H11FN2OS
Acta Crystallographica Section E (2014) 70, 9 o1023-o1024
a=9.6265(4)Å b=11.1329(4)Å c=13.8252(5)Å
α=110.646(3)° β=100.708(3)° γ=102.762(3)°
3-Hydroxy-2-(toluene-4-sulfonylamino)-propionic acid
C10H13NO5S
Crystal Growth & Design (2014) 14, 4 1938
a=4.9709(2)Å b=9.7703(5)Å c=24.2865(13)Å
α=90.00° β=90.00° γ=90.00°